Skip to main content

Aptose Biosciences Inc.

APTODelisted Jul 21, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000882361

Aptose Biosciences Inc. was delisted on Jul 21, 2025; its insiders filed their last Form 4 on Jul 2, 2026; 16 institutions reported holding it in 13F filings for Q1 2025, worth $486.8K in total; no superinvestor held it.

Q2 2023 vs. Q1 2023

How the institutions holding Aptose Biosciences Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of APTO: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders4525−20
SharesConverted for a 1-for-15 split1.40M1.01M−392.1K (−27.9%)
Value$13.5M$4.71M−$8.80M (−65.1%)

New holders (3)

Institutions that held Aptose Biosciences Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to APTO in Q2 2023
InstitutionSharesValue% of portfolio
Bank of America Corp100$4640.00%
Caldwell Sutter Capital, Inc.92$4270.00%
Tower Research Capital LLC (TRC)29$1350.00%

Sold out (23)

Institutions that held Aptose Biosciences Inc. at the end of Q1 2023 and filed for Q2 2023 without it.